Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI

被引：0
|
作者：
Sandborn, W. J. [1 ]
Sands, B. E. [2 ]
Panaccione, R. [3 ]
O'Brien, C. D. [4 ]
Zhang, H. [4 ]
Johanns, J. [4 ]
Peyrin-Biroulet, L. [5 ]
Van Assche, G. [6 ]
Danese, S. [7 ]
Targan, S. R. [8 ]
Abreu, M. T. [9 ]
Hisamatsu, T. [10 ]
Szapary, P. [4 ]
Marano, C. [4 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Calgary, Calgary, AB, Canada
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Univ Lorraine, Nancy Univ Hosp, Nancy, France
[6] Univ Leuven, Leuven, Belgium
[7] Humanitas Res Hosp, Milan, Italy
[8] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[9] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[10] Kyorin Univ, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP37
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [31] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen
    Leong, Rupert
    Arasaradnam, Ramesh
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315
  • [32] ECCO 2019 First Results on Ustekinumab Maintenance Therapy in moderate to severe active Ulcerative Colitis
    不详
    VISCERAL MEDICINE, 2019, 35 (04) : 276 - 276
  • [33] Molecular Response to Ustekinumab in Moderate-to-Severe Ulcerative Colitis by Serum Protein and Colon Transcriptomic Analysis: Results From the UNIFI Phase 3 Maintenance Study
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen
    Friedman, Joshua R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S378 - S379
  • [34] Effects of ustekinumab induction therapy on endoscopic and histological healing in the UNIFI Phase 3 study in ulcerative colitis
    Li, K.
    Friedman, J. R.
    Marano, C.
    Zhang, H.
    Yang, F.
    Feagan, B. G.
    Peyrin-Biroulet, L.
    De Hertogh, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S73 - S73
  • [35] EFFECTS OF USTEKINUMAB INDUCTION THERAPY ON ENDOSCOPIC AND HISTOLOGIC HEALING IN THE UNIFI PHASE 3 STUDY IN ULCERATIVE COLITIS
    Li, Katherine
    Friedman, Joshua R.
    Marano, Colleen W.
    Zhang, Hongyan
    Yang, Feifei
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    De Hertogh, Gert
    GASTROENTEROLOGY, 2019, 156 (06) : S1104 - S1104
  • [36] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION
    Abreu, Maria T.
    Sands, Bruce E.
    Leong, Rupert W.
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Zhou, Yiying
    Johanns, Jewel
    Rowbotham, David
    Hisamatsu, Tadakazu
    Arasaradnam, Ramesh P.
    Scherl, Ellen J.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2020, 158 (06) : S1201 - S1201
  • [37] Efficacy and safety of long-term treatment with ustekinumab in moderate-severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extension
    Sands, B. E.
    Abreu, M. T.
    Leong, R. W. L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Zhou, Y.
    Johanns, J.
    Rowbotham, D.
    Hisamatsu, T.
    Arasaradnam, R. P.
    Scherl, E.
    Danese, S.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S476 - S477
  • [38] Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
    Gisbert, Javier P.
    Parody-Rua, Elizabeth
    Chaparro, Maria
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 292 - 302
  • [39] THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
    Rubin, David T.
    Allegretti, Jessica R.
    Panes, Julian
    Shipitofsky, Nicole
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Wilson, Rebbecca
    Zhang, Hongyan
    Feagan, Brian G.
    Hisamatsu, Tadakazu
    Lichtenstein, Gary R.
    Bressler, Brian
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Dignass, Axel
    GASTROENTEROLOGY, 2024, 166 (05) : S180 - S180
  • [40] Efficacy in biological therapy failure and nonbiological therapy failure populations in a Phase III study of ustekinumab in moderate-severe ulcerative colitis: UNIFI study
    Sands, B.
    Peyrin-Biroulet, L.
    Marano, C.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Rowbotham, D.
    Leong, R.
    Arasaradnam, R.
    Danese, S.
    Van Assche, G.
    Targan, S.
    Sandborn, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 131 - 133
12345